Royal Bank of Canada
DERM icon

Royal Bank of Canada’s Journey Medical DERM Stock Holding History

Royal Bank of Canada’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38K Buy
8,175
+2,446
+43% +$19K ﹤0.01% 5619
2025
Q4 		$44K Buy
5,729
+328
+6% +$2.57K ﹤0.01% 5615
2025
Q3 		$38K Buy
5,401
+3,560
+193% +$25.8K ﹤0.01% 5937
2025
Q2 		$13K Buy
1,841
+1,591
+636% +$11K ﹤0.01% 6401
2025
Q1 		$1K Hold
250
– – ﹤0.01% 6645
2024
Q4 		$1K Hold
250
– – ﹤0.01% 6767
2024
Q3 		$1K Sell
250
-121
-33% -$623 ﹤0.01% 6696
2024
Q2 		$2K Buy
371
+365
+6,083% +$1.5K ﹤0.01% 6716
2024
Q1 		$0 Sell
6
-23
-79% -$100 ﹤0.01% 7119
2023
Q4 		$0 Buy
29
+14
+93% +$62 ﹤0.01% 7208
2023
Q3 		$0 Sell
15
-63
-81% -$141 ﹤0.01% 7171
2023
Q2 		$0 Buy
+78
New +$125 ﹤0.01% 7331
2022
Q4 		– Sell
-47
Closed – – 7317
2022
Q3 		$0 Buy
+47
New +$160 ﹤0.01% 7514
2022
Q1 		– Sell
-2,500
Closed -$13K – 7787
2021
Q4 		$13K Buy
+2,500
New +$18.1K ﹤0.01% 6966

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royal Bank of Canada's DERM Position: Q1 2026 in Review

Royal Bank of Canada increased its Journey Medical (DERM) stake by 43% in Q1 2026, buying an estimated $19K and bringing the position to 8,175 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #5619.

Royal Bank of Canada first reported a position in DERM in Q4 2021 and has held it in 14 quarters since. The position peaked at $44K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Royal Bank of Canada held 8,175 shares of Journey Medical worth $38K as of Q1 2026.
  • Royal Bank of Canada bought 2,446 Journey Medical shares in Q1 2026, an estimated $19K.
  • Journey Medical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5619 holding.
  • Royal Bank of Canada first reported a position in Journey Medical in Q4 2021 and has held it in 14 quarters since.
  • Royal Bank of Canada's Journey Medical position peaked at $44K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.